Hims & Hers Health, Inc. (NYSE:HIMS) Insider Sells $73,053.28 in Stock
Hims & Hers Health, Inc. (NYSE:HIMS) Insider Sells $73,053.28 in Stock
Hims & Hers Health, Inc. (NYSE:HIMS – Get Rating) insider Irene Becklund sold 11,002 shares of Hims & Hers Health stock in a transaction on Friday, September 9th. The shares were sold at an average price of $6.64, for a total transaction of $73,053.28. Following the completion of the sale, the insider now owns 2,715 shares in the company, valued at approximately $18,027.60. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.
Hims&Hers Health,Inc.(紐約證券交易所代碼:HIMS-GET Rating)內部人士艾琳·貝克倫德在9月9日星期五的一筆交易中出售了11,002股Hims&Hers Health股票。這些股票以6.64美元的平均價格出售,總成交額為73,053.28美元。出售完成後,這位內部人士現在擁有該公司2,715股股票,價值約18,027.60美元。這筆交易是在提交給美國證券交易委員會的一份法律文件中披露的,可以通過以下鏈接訪問該文件。
Irene Becklund also recently made the following trade(s):
艾琳·貝克倫德最近還做了以下交易:
- On Tuesday, July 5th, Irene Becklund sold 19,331 shares of Hims & Hers Health stock. The shares were sold at an average price of $5.00, for a total transaction of $96,655.00.
- 7月5日,星期二,艾琳·貝克倫德出售了19331股Hims&Her Health股票。這些股票以5美元的平均價格出售,總成交金額為96,655.00美元。
Hims & Hers Health Stock Down 0.6 %
HIMS&HERS健康類股下跌0.6%
NYSE HIMS opened at $6.64 on Tuesday. Hims & Hers Health, Inc. has a 52 week low of $2.72 and a 52 week high of $9.35. The firm has a market capitalization of $1.36 billion, a P/E ratio of -16.19 and a beta of 0.46. The company has a 50-day moving average price of $6.14 and a 200-day moving average price of $5.05.
紐約證交所HIM週二開盤報6.64美元。Hims&Hers Health,Inc.的股價為2.72美元,為52周低點,52周高點為9.35美元。該公司的市值為13.6億美元,市盈率為-16.19,貝塔係數為0.46。該公司的50日移動均線價格為6.14美元,200日移動均線價格為5.05美元。
Wall Street Analysts Forecast Growth
華爾街分析師預測經濟增長
A number of brokerages have recently commented on HIMS. Guggenheim boosted their target price on shares of Hims & Hers Health to $12.00 in a report on Monday, August 15th. Deutsche Bank Aktiengesellschaft boosted their target price on shares of Hims & Hers Health from $7.00 to $8.00 in a report on Wednesday, August 10th. SVB Leerink upped their price target on shares of Hims & Hers Health from $4.00 to $5.00 and gave the stock an "underperform" rating in a research note on Tuesday, August 9th. Truist Financial assumed coverage on shares of Hims & Hers Health in a research note on Wednesday, September 7th. They issued a "hold" rating and a $7.00 price target on the stock. Finally, Piper Sandler dropped their price target on shares of Hims & Hers Health from $8.00 to $6.00 and set an "overweight" rating on the stock in a research note on Thursday, May 26th. One analyst has rated the stock with a sell rating, three have given a hold rating and four have issued a buy rating to the stock. According to MarketBeat, Hims & Hers Health currently has a consensus rating of "Hold" and an average target price of $7.38.
最近,許多券商都對他發表了評論。古根海姆在8月15日星期一的一份報告中將Hims&Hers Health的目標股價上調至12.00美元。德意志銀行Aktiengesellschaft在8月10日星期三的一份報告中將Hims&Hers Health的股票目標價從7.00美元上調至8.00美元。8月9日,週二,SVB Leerink在一份研究報告中將Hims&Hers Health的目標價從4.00美元上調至5.00美元,並將該股的評級定為“表現不佳”。Truist Financial在9月7日星期三的一份研究報告中對Hims&Hers Health的股票進行了報道。他們對該股的評級為“持有”,目標價為7美元。最後,派珀·桑德勒將Hims&Hers Health股票的目標價從8.00美元下調至6.00美元,並在5月26日星期四的一份研究報告中對該股設定了“增持”評級。一名分析師對該股的評級為賣出,三名分析師給予持有評級,四名分析師對該股給予買入評級。根據MarketBeat,Hims&Hers Health目前的共識評級為持有,平均目標價為7.38美元。
Institutional Investors Weigh In On Hims & Hers Health
機構投資者關注Hims&His的健康狀況
Hedge funds and other institutional investors have recently made changes to their positions in the business. Teacher Retirement System of Texas grew its stake in shares of Hims & Hers Health by 25.6% during the 4th quarter. Teacher Retirement System of Texas now owns 14,808 shares of the company's stock valued at $97,000 after acquiring an additional 3,022 shares during the period. Northern Trust Corp grew its stake in shares of Hims & Hers Health by 1.3% during the 1st quarter. Northern Trust Corp now owns 253,307 shares of the company's stock valued at $1,350,000 after acquiring an additional 3,226 shares during the period. HighTower Advisors LLC grew its stake in shares of Hims & Hers Health by 14.4% during the 4th quarter. HighTower Advisors LLC now owns 31,761 shares of the company's stock valued at $209,000 after acquiring an additional 3,998 shares during the period. Royal Bank of Canada grew its stake in shares of Hims & Hers Health by 18.4% during the 1st quarter. Royal Bank of Canada now owns 26,523 shares of the company's stock valued at $140,000 after acquiring an additional 4,126 shares during the period. Finally, Baldwin Brothers LLC MA grew its stake in shares of Hims & Hers Health by 21.5% during the 1st quarter. Baldwin Brothers LLC MA now owns 27,605 shares of the company's stock valued at $147,000 after acquiring an additional 4,889 shares during the period. Hedge funds and other institutional investors own 43.41% of the company's stock.
對衝基金和其他機構投資者最近對他們在該業務中的頭寸進行了調整。德克薩斯州教師退休系統在第四季度增持了Hims&Hers Health的股份25.6%。德克薩斯州教師退休系統在此期間額外購買了3,022股,現在擁有14,808股該公司股票,價值97,000美元。第一季度,北方信託公司在Hims&Hers Health的持股增加了1.3%。北方信託公司目前擁有253,307股該公司股票,價值1,350,000美元,在此期間又購買了3,226股。HighTower Advisors LLC在第四季度增持了Hims&Hers Health的股份14.4%。HighTower Advisors LLC在此期間增持了3998股,目前擁有31,761股該公司股票,價值20.9萬美元。今年第一季度,加拿大皇家銀行在海姆斯健康集團的持股增加了18.4%。加拿大皇家銀行在此期間增持了4,126股,現在持有26,523股該公司股票,價值140,000美元。最後,鮑德温兄弟有限責任公司在第一季度增持了Hims&Hers Health的股份21.5%。鮑德温兄弟有限責任公司現在擁有27,605股該公司的股票,價值147,000美元,在此期間又購買了4,889股。對衝基金和其他機構投資者持有該公司43.41%的股份。
About Hims & Hers Health
關於希姆斯和她的健康
(Get Rating)
(獲取評級)
Hims & Hers Health, Inc operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products, primarily focusing on wellness, sexual health and wellness, skincare, and hair care.
Hims&Hers Health,Inc.運營着一個多專業遠程醫療平臺,將消費者與有執照的醫療保健專業人員聯繫起來。該公司提供一系列健康和健康產品和服務,可在其網站和移動應用程序上直接由客户購買。它還提供定期的處方藥和醫療保健提供者的持續護理;以及非處方藥和設備產品、化粧品和補充劑產品,主要側重於健康、性健康和健康、皮膚護理和頭髮護理。
Featured Articles
專題文章
- Get a free copy of the StockNews.com research report on Hims & Hers Health (HIMS)
- Do These Dividend Achievers Deserve A Place In Your Portfolio?
- Darden Restaurants Takes the Low Road Against Inflation
- Why These 3 Stocks Are Off to Hot September Starts
- Inflation Doesn't Differentiate, But it's Impact Does
- 3 Downgraded Must-Have Stocks To Put On Your Watchlist
- 免費獲取StockNews.com關於他和她的健康的研究報告(HIMS)
- 這些股息獲得者值得在你的投資組合中佔有一席之地嗎?
- 達頓餐廳走低通脹之路
- 這3只股票為何在9月火爆開盤
- 通貨膨脹沒有差別,但它的影響有差別
- 3只被降級的必備股票放在你的觀察名單上
Receive News & Ratings for Hims & Hers Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hims & Hers Health and related companies with MarketBeat.com's FREE daily email newsletter.
接受《健康日報》的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對Hims&Hers Health和相關公司的最新新聞和分析師評級的每日簡要摘要。